Fibronectin Polypeptide Fragments for Growth Factor Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies lack effective methods for identifying and utilizing polypeptides derived from fibronectin and vitronectin that can bind to growth factors or enhance their activity, which are crucial for various biological processes such as wound healing and cancer treatment.
Innovation Solution
Development of methods to identify and utilize polypeptide fragments from fibronectin and vitronectin that bind to growth factors, including the use of phage display to find binding partners, and the creation of compositions that include these fragments to promote or inhibit fibronectin and vitronectin binding, enhancing growth factor activity for therapeutic and cosmetic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polypeptide fragments from fibronectin and vitronectin are identified and used to bind growth factors, then growth factor activity is enhanced and tissue repair is improved, but the complexity of identifying and characterizing these polypeptides increases
Solution Approach 1:
The patent segments fibronectin and vitronectin into specific functional domains (FNIII1-2, H, HV, and other type III repeats) that can independently bind growth factors. This segmentation allows identification of minimal functional units rather than requiring characterization of entire proteins, reducing complexity while maintaining binding activity.
Solution Approach 2:
The patent extracts specific growth factor-binding domains from full-length fibronectin and vitronectin proteins. By taking out only the essential binding regions (such as FNIII1-2, H, and HV domains), the invention simplifies the polypeptide structures needed for growth factor enhancement while eliminating unnecessary complex regions.
2Measurement precision
If phage display and screening assays are used to identify binding polypeptides, then specific growth factor binders are found, but the time and resources required for screening increase
Solution Approach 1:
The patent performs preliminary action by directly identifying and characterizing specific fibronectin and vitronectin domains known to bind growth factors (FNIII1-2, H, HV domains). Rather than conducting broad random screenings, the invention pre-identifies the relevant domains based on their established binding capabilities, significantly reducing screening time while maintaining high specificity.
3Reliability
If fibronectin fragments are used to support FN-null cell viability, then cell survival is promoted, but the requirement for specific domain combinations increases complexity
Solution Approach 1:
The patent extracts the minimal essential domains from fibronectin required for FN-null cell viability. By identifying and using only the necessary domains (such as FNIII8-11 for cell binding and FNIII1-2, H, or HV for growth factor enhancement), the invention reduces the complexity of domain combinations while maintaining cell survival support.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The identified polypeptide fragments retain or enhance the biological activity of growth factors, facilitating their use in promoting wound healing, cancer treatment, and cosmetic treatments by effectively binding and delivering growth factors to specific sites, thereby improving tissue repair and regeneration.
Implementation Method 1
fragments of fibronectin (FN), including fragments within domains FNIII1-2, H and HV, bind growth factors
Data Source
AI summary
Described herein are fragments of fibronectin and vitronectin and variants thereof that have certain activities, including growth factor-binding activity. Also described are fragments of growth factors that bind to fibronectin and inhibit binding of full-length growth factors to fibronectin. Compositions containing such fragments are useful in cosmetic treatments (e.g., the treatment of wrinkles or UV photodamage of skin), and the treatment of wounds and cancer.